Literature DB >> 21825188

Geographic and climatic factors associated with exfoliation syndrome.

Joshua D Stein1, Louis R Pasquale, Nidhi Talwar, Denise S Kim, David M Reed, Bin Nan, Jae Hee Kang, Janey L Wiggs, Julia E Richards.   

Abstract

OBJECTIVE: To identify geographic and climatic risk factors associated with exfoliation syndrome (ES).
METHODS: A retrospective study of 626 901 eye care recipients, dating from 2001 to 2007 from 47 US states in a managed care network. Incident ES cases-patients (N = 3367) were identified by using billing codes. We assessed the risk of ES by geographic latitude tier in the continental United States and assigned state-level climatic data (eg, ambient temperature, elevation, and sun exposure) according to patients' residential location. The hazard of ES was calculated by using multivariable-adjusted Cox proportional hazards regression models.
RESULTS: Compared with middle-tier residence, northern-tier residence (above 42°N) was associated with an increased hazard of ES (adjusted hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.94-2.35). Southern-tier (below 37°N) was associated with a reduced hazard of ES (HR, 0.83; 95% CI, 0.75-0.93). Excluding whites did not change these associations. After adjustment for joint environmental effects, for every 1° increase in July high temperature, the hazard of ES decreased by 9% (HR, 0.91; 95% CI, 0.89-0.93); for every 1° increase in January low temperature, the hazard decreased 3% (0.97; 0.96-0.98). For each additional sunny day annually, the hazard increased by 1.5% (HR, 1.02; 95% CI, 1.01-1.02) in locations with average levels of other climatic factors.
CONCLUSION: Ambient temperature and sun exposure may be important environmental triggers of ES.

Entities:  

Mesh:

Year:  2011        PMID: 21825188      PMCID: PMC3198850          DOI: 10.1001/archophthalmol.2011.191

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  63 in total

1.  The frequency of senile exfoliation in Iceland. Fibrillopathy or pseudoexfoliation.

Authors:  K Sveinsson
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

2.  Pseudoexfoliation and sensorineural hearing loss.

Authors:  M Cahill; A Early; S Stack; A W Blayney; P Eustace
Journal:  Eye (Lond)       Date:  2002-05       Impact factor: 3.775

3.  Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron microscopic study.

Authors:  C Cursiefen; T Hammer; M Küchle; G O Naumann; U Schlötzer-Schrehardt
Journal:  Acta Ophthalmol Scand       Date:  2001-10

4.  Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report.

Authors:  Siv Aström; Christina Lindén
Journal:  Acta Ophthalmol Scand       Date:  2007-11-06

5.  Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.

Authors:  Sebastian Schneeweiss; Mike Doherty; Shao Zhu; Donnie Funch; Raymond G Schlienger; Carlos Fernandez-Vidaurre; John D Seeger
Journal:  Dermatology       Date:  2009-03-17       Impact factor: 5.366

Review 6.  Is exfoliation syndrome a sign of systemic vascular disease?

Authors:  Ahti Tarkkanen
Journal:  Acta Ophthalmol       Date:  2008-12       Impact factor: 3.761

7.  Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables.

Authors:  Arsaell Arnarsson; Karim F Damji; Thordur Sverrisson; Hiroshi Sasaki; Fridbert Jonasson
Journal:  Acta Ophthalmol Scand       Date:  2007-12

8.  Sensorineural hearing loss in pseudoexfoliation.

Authors:  M Erol Turacli; Filiz A Ozdemir; Oya Tekeli; Kürsat Gökcan; Muharrem Gerçeker; Kudret Dürük
Journal:  Can J Ophthalmol       Date:  2007-02       Impact factor: 1.882

9.  Hyperhomocystinemia in pseudoexfoliation glaucoma.

Authors:  Igal Leibovitch; Shimon Kurtz; Gabi Shemesh; Michaella Goldstein; Ben-ami Sela; Moshe Lazar; Anat Loewenstein
Journal:  J Glaucoma       Date:  2003-02       Impact factor: 2.503

10.  Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma.

Authors:  Tongabay Cumurcu; Semsettin Sahin; Erdinc Aydin
Journal:  BMC Ophthalmol       Date:  2006-02-23       Impact factor: 2.209

View more
  41 in total

1.  Relation between time spent outdoors and exfoliation glaucoma or exfoliation glaucoma suspect.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Am J Ophthalmol       Date:  2014-05-20       Impact factor: 5.258

Review 2.  Exfoliation syndrome in sub-Saharan Africa.

Authors:  Olusola O Olawoye; Louis R Pasquale; Robert Ritch
Journal:  Int Ophthalmol       Date:  2014-05-21       Impact factor: 2.031

3.  Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts.

Authors:  Jae Hee Kang; Stephanie Loomis; Janey L Wiggs; Joshua D Stein; Louis R Pasquale
Journal:  Ophthalmology       Date:  2011-10-07       Impact factor: 12.079

4.  Solar exposure and residential geographic history in relation to exfoliation syndrome in the United States and Israel.

Authors:  Louis R Pasquale; Aliya Z Jiwani; Tzukit Zehavi-Dorin; Arow Majd; Douglas J Rhee; Teresa Chen; Angela Turalba; Lucy Shen; Stacey Brauner; Cynthia Grosskreutz; Matthew Gardiner; Sherleen Chen; Sheila Borboli-Gerogiannis; Scott H Greenstein; Kenneth Chang; Robert Ritch; Stephanie Loomis; Jae H Kang; Janey L Wiggs; Hani Levkovitch-Verbin
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

Review 5.  Common and rare genetic risk factors for glaucoma.

Authors:  Ryan Wang; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-18       Impact factor: 6.915

6.  A Pilot Study to Evaluate the Oral Microbiome and Dental Health in Primary Open-Angle Glaucoma.

Authors:  Daniel Polla; Konstantin Astafurov; Eman Hawy; Leslie Hyman; Wei Hou; John Danias
Journal:  J Glaucoma       Date:  2017-04       Impact factor: 2.503

7.  Impact of the introduction of generic latanoprost on glaucoma medication adherence.

Authors:  Joshua D Stein; Nakul Shekhawat; Nidhi Talwar; Rajesh Balkrishnan
Journal:  Ophthalmology       Date:  2015-02-09       Impact factor: 12.079

Review 8.  Use of health care claims data to study patients with ophthalmologic conditions.

Authors:  Joshua D Stein; Flora Lum; Paul P Lee; William L Rich; Anne L Coleman
Journal:  Ophthalmology       Date:  2014-01-14       Impact factor: 12.079

Review 9.  Exfoliation Syndrome and Solar Exposure: New Epidemiological Insights Into the Pathophysiology of the Disease.

Authors:  Aliya Z Jiwani; Louis R Pasquale
Journal:  Int Ophthalmol Clin       Date:  2015

10.  Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).

Authors:  Janey L Wiggs; Basil Pawlyk; Edward Connolly; Michael Adamian; Joan W Miller; Louis R Pasquale; Ramez I Haddadin; Cynthia L Grosskreutz; Douglas J Rhee; Tiansen Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.